C3.ai Inc vs Baxter International Inc — how do they compare? C3.ai Inc trades at $10.6 (market cap $1.59B), while Baxter International Inc trades at $27.61 (market cap $14.36B). The key difference: Baxter International Inc is far larger — about 9× C3.ai Inc's market cap, and Baxter International Inc pays a 0.14% dividend while C3.ai Inc pays none. Which is the better fit depends on your goals.
| AI | BAX | |
|---|---|---|
Market Cap | $1.59B | $14.36B |
Sector | Technology | Health |
52-Week High | $19.66 | $28.35 |
52-Week Low | $7.76 | $15.80 |
Enterprise Value | $1.02B | $21.88B |
Dividend Yield | — | 0.14% |
Trailing returns across standard periods
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →